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ABSTRACT
Objective: The aim of this study was to evaluate 2,4-dichlorobenzoic acid derivatives as antimicrobial agents through in vitro, QSAR and molecular 
docking studies.
Methods: The compounds were subjected to in vitro antimicrobial screening by test tube dilution method and the structural characteristics governing 
the antimicrobial potential were studied using QSAR methodology. These compounds were also screened for docking simulation to find out binding 
confirmation of reported compounds with PDB 1aj0 and 5fsa using AutoDock tools and discovery studio.
Results: The antimicrobial evaluation data indicated that compounds 13 and 18 were found to be the most effective against all the bacterial strains 
and Aspergillus niger while compounds 1 and 14 exhibited more antifungal potential against Candida albicans. QSAR studies confirmed the role of 
molar refractivity and Balaban index (J) as controlling parameters for antimicrobial potential. Molecular modeling study revealed that compounds 
interact with the active site of PDB by hydrophobic, hydrogen bonding, and Van der Wall interactions.
Conclusion: These test compounds were identified as potent candidates for the control of microbial strains tested, and structural relationship with 
activity may provide valuable information for further design and synthesis of compounds with antimicrobial potential.
Keywords: Antimicrobial, QSAR, Molecular docking.
INTRODUCTION
The multidrug resistance associated with life-threatening microbial 
infections is a re-emerging and alarming microbial threat and amenable 
for millions of deaths annually due to the inadequacy of efficacious 
antimicrobial drugs [1]. To improve the current antimicrobial 
therapies, several studies have been conducted to improve the available 
treatments, but due to the continuance of the antibiotic resistance, 
pathogens have become a critical and complicated health issue [2].
Sulfonamides, being antibacterial, having the prominent mechanism of 
action including attachment of sulfonamides with the dihydropteroate 
synthetase (DHPS) enzyme and alteration of bacterial pathways of 
folic acid synthesis in few eukaryotic cells, but in human beings, 
this mechanism is not followed [3,4]. The sulfonamides have been 
recognized due to various reported biological activities such as 
anticancer [5-9], anti-Alzheimer [10,11], anti-tubercular [12,13], 
antimicrobial [14-17], anti-inflammatory [18], carbonic anhydrase 
inhibitors [19-22], antidiabetic [11], anticonvulsant [23], and 
antimalarial [24-26].
Due to these facts, there is a prime need to shorten the duration 
of therapy and ascertain newer antimicrobial agents to avert the 
emergence of resistance. In continuation of our efforts dedicated toward 
development of antimicrobials, we have screened compounds (1-18) 
reported by Thakral and Singh [27] for antimicrobial potential along 
with QSAR and computational studies.
METHODS
Antimicrobial evaluation
The reported compounds were evaluated for their in vitro antimicrobial 
potential against bacterial and fungal strains through serial dilution 
technique to get their minimum inhibitory concentration [28]. The 
weighed amount of nutrient broth and Sabouraud dextrose broth was 
dissolved in distilled water to prepare nutrient medium for bacteria 
and fungus, respectively, and 1 ml of nutrient medium was transferred 
to each test tube. The test sample compound (0.01 g) was dissolved in 
10 ml of dry dimethyl sulfoxide to give a stock solution of 100 µg/ml. 
The 1 ml solution of test compounds was transferred to test tubes 
having sterilized nutrient medium and diluted serially to get a set of 
five dilutions of test compounds having concentrations 50, 25, 12.5, 
6.25, and 3.125 µg/ml. Minimal inhibitory concentration for each 
sample was investigated against Gram-positive bacterial strains; 
Bacillus subtilis (MTCC 441), Staphylococcus aureus (MTCC 7443), and 
Staphylococcus epidermidis (MTCC 435), two Gram-negative bacterial 
strains; Escherichia coli (MTCC 1652) and Pseudomonas aeruginosa 
(MTCC 424), and two fungal strains; Aspergillus niger (MTCC 8189) 
and Candida albicans (MTCC 227). The freshly cultured strains of each 
organism were transferred in to test tubes and incubated at 37±1°C for 
24 h for bacterial strains, 48 h for C. albicans and 7 days at 25±1°C for 
A. niger. Ciprofloxacin was considered as a standard for antibacterial 
and fluconazole for antifungal activity.
QSAR
The two-dimensional structures were drawn, and energy minimization 
was done by molecular mechanics force field (MM) process of 
hyperchem 6.03 (1993), and the pre-optimization of the energy 
minimized structures was done. The calculation of physicochemical 
parameters for each compound was done using TSAR 3.3 software for 
Windows (2000) and the SPSS software package (1999) was used for 
regression analysis [29,30].
Molecular modeling
The advanced docking program, AutoDock Vina was used to evaluate the 
binding properties of test compounds into microbial targets [31]. 
The crystal structures of a ternary complex of E. coli dihydropteroate 
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synthase (1aj0) [32] and sterol 14-alpha-demethylase (CYP51) from a 
pathogenic yeast Candida albicans in complex with the antifungal drug 
posaconazole (5fsa) [33,34] were downloaded from the protein data 
bank (www.rcsb.org). All bound water molecules and cocrystallized 
ligands were removed from protein, and polar hydrogen atoms were 
added. 2D structure of ligands was penciled in MarvinSketch and saved 
in pdb format, then further saved into pdbqt format using AutoDock 
Vina. Energy minimization was performed using the MMFF94 force 
field. Then docking was performed according to specified conditions 
of grid box used by AutoDock tools. The Vina search space chosen was 
center_x = 39.66, center_y = 7.14, center_z = 2.63; center_x = 193.6, 
center_y = 1.0, center_z = 39.0 and size_x=40, size_y=40, size_z = 40 for 
1aj0, 5fsa, respectively. The exhaustiveness was set to be 8.
RESULTS AND DISCUSSION
In vitro antimicrobial studies
All the compounds were evaluated for their in vitro antibacterial activity 
against S. aureus, B. subtilis, and S. epidermidis (Gram-positive bacteria), 
and E. coli and P. aeruginosa (Gram-negative bacteria), and antifungal 
potential against C. albicans and A. niger. The power management 
integrated circuit (pMIC) values obtained are recorded in Table 1.
Based on results, it could be inferred that compounds 13 and 18 have the 
highest and broad spectrum of antimicrobial potential while compound 
2 exerted the highest activity against S. epidermidis with a pMIC value of 
1.785 µM. Compounds 1, 3, and 11 exhibited good antimicrobial activity 
against all strains. Compounds 1 and 14 exhibited the most potent 
antifungal activity against C. albicans with a pMIC value of 2.102 µM. All 
other test compounds showed moderate antimicrobial potential against 
all bacterial and fungal strains. Compounds 13 and 18 also displayed 
more inhibition effect against A. niger species. Compounds 1, 3, 11, and 
14 exhibited good antifungal potential against A. niger.
It is observed that in this series compound 2 with p-Cl substituent 
showed selective inhibition against S. epidermidis whereas the activity 
was diminished when substituted with the o-NO2 group. Results revealed 
that chloro substituent on phenyl ring exerted higher activity against 
all microbial strains as compared to fluoro substituent. Apparently, 
the compound bearing methoxy group displayed more antimicrobial 
potential as compared to methyl substituted compound. Replacement 
of aromatic anilines with aliphatic amines as observed in compounds 
15, 16, and 17, afforded a decrease in antimicrobial potential against 
all strains. A deep insight into the structure of test compounds revealed 
that their antimicrobial activity seems to be modulated by the effect 
of the substituent. Above all, it could be inferred that a significant 
broad spectrum of antimicrobial activity was allied with compounds 
incorporating electron withdrawing substitution [17].
General structure of 2,4-dichlorobenzoic acid derivatives.
QSAR study
In this present study, dataset of 18 compounds (1-18) was used to 
establish a quantitative relationship between antimicrobial activity 
and structural descriptors of substituted sulfonamide derivatives. 
The structural descriptors coding for lipophilic, steric, electronic, and 
molecular connectivity were used in this study, and the corresponding 
value for each molecular descriptor is presented in Table 2. A correlation 
matrix was constructed to find out the inter-relationship of different 
calculated molecular descriptors and antimicrobial activity as well as inter-
relationship of different molecular descriptors with each other (Table 3).
It was observed from correlation matrix that highest correlation existed 
between Randic parameter (R) and first-order molecular connectivity 
index (1χ, r=1.000) and between Weiner index (W) and zero-order 
molecular connectivity index (0χ, r=0.995). The least interrelationship was 
observed for the energy of highest occupied molecular orbital (HOMO) 
and energy of lowest unoccupied molecular orbital (r=0.050) and energy 
of HOMO and third-order alpha shape indices (kα3, r=−0.063). In general 
high inter-relationship was observed for different calculated molecular 
descriptors with each other. The correlation of molecular descriptors with 
respective antibacterial and antifungal activity is presented in Table 4.
The different molecular descriptors were subjected to linear free 
energy regression analysis with antibacterial activity against S. aureus 
and a mathematical model (Eq. 1) illustrating the importance of molar 
refractivity (MR) was obtained.
pMICsa= 0.052 MR +1.039 (1)
n=18, r=0.970, r2=0.940, q2=0.929, s=0.009, F=256.482
The QSAR model represented by Equation 1 is monoparametric and 
based on the number of compounds included in the dataset and the rule 
of thumb directed us to go for development of multiparametric models 
which can quantify the activity of test molecules against S. aureus. The 
dataset was subjected to multiple linear regression analysis and Equation 
2 was obtained which depicted the role of the energy of HOMO along with 
MR in modulating the observed antibacterial against S. aureus.
pMICsaMLR = 0.0055 MR - 0.0068 HOMO + 0.954 (2)
n=18, r=0.974, r2=0.949, q2=0.926, s=0.0087, F=139.817
An effort was made to further enhance the r value of QSAR model 
represented by Equation 2 and a detailed investigation of this model 
depicted that compound 6 was acting as an outlier whose response 
values were outside the expected limits.Hence, Compound 6 was 
excluded from the study (being an outlier), and a new QSAR model was 
obtained, represented by Equation 3, with improved r, r2, q2, F values, 
and low S values.
pMICsaMLR= 0.0054 MR - 0.0044 HOMO + 0.983 (3)
n=17, r= 0.981, r2=0.963, q2=0.937, s=0.0077, F=181.325
Equation 3 was used to predict the antibacterial activity of test 
compounds against S. aureus and a comparison of observed, predicted 
and residual antibacterial activity is presented in Table 5.
The results presented in Table 5 revealed that low residual values for 
antibacterial activity were obtained using QSAR model represented by 
Equation 3 which suggest that the developed model was a valid one. 
Same QSAR models were obtained for antibacterial activity of test 
compounds against B. subtilis, P. aeruginosa, E. coli, and antifungal 
activity against A. niger.
To develop QSAR model for antifungal activity of test compounds 
against C. albicans, the entire dataset was subjected to regression 
analysis and Equation 4 was obtained in which Balaban index (J) was 
found to be effectively controlling the antifungal activity.
pMICca = −0.414 J+ 2.72 9 (4)
n=18, r=0.643, r2=0.414, q2=0.325, s=0.131, F=11.300
The r value in Equation 4 was 0.643 which was less than the required 
limit (r≥0.7) and the outcomes of Equation 4 were studied in detail to 
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Table 1: In vitro antimicrobial activity of 2,4-dichlorosubstituted derivatives in terms of pMIC values (µmol/ml) 
Comp. R pMICsa pMICbs pMICse pMICec pMICpa pMICca pMICan
pMIC (µmol)
1 1.496 1.496 1.496 1.496 1.496 2.102 1.496
2 1.484 1.484 1.785 1.484 1.484 2.086 1.484
3 1.496 1.496 0.893 1.496 1.496 1.799 1.496
4 1.484 1.484 1.484 1.484 1.484 2.086 1.484
5 1.479 1.479 1.479 1.479 1.479 2.081 1.479
6 1.460 1.460 1.460 1.460 1.460 2.066 1.460
7 1.479 1.479 1.479 1.479 1.479 2.081 1.479
8 1.465 1.465 1.465 1.465 1.465 2.071 1.465
9 H3CO 1.479 1.479 1.479 1.479 1.479 2.081 1.479
10 1.484 1.484 1.484 1.484 1.484 1.785 1.484
11 1.500 1.500 1.500 1.500 1.500 1.801 1.500
12 1.465 1.465 1.465 1.465 1.465 1.767 1.465
13 1.533 1.533 1.533 1.533 1.533 1.836 1.533
14 1.496 1.496 1.496 1.496 1.496 2.102 1.496
15 Butyl 1.417 1.417 1.417 1.417 1.417 1.719 1.417
16 Propyl 1.398 1.398 1.398 1.398 1.398 1.699 1.398
17 Isopropyl 1.398 1.398 1.398 1.398 1.398 1.699 1.398
18 1.511 1.511 1.511 1.511 1.511 1.812 1.511
pMIC: Power management integrated circuit
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find out the reason for low r value and it was found that compounds 3, 
10, 11, 12, and 18 were behaving as outliers as their response values 
were outside the experimental limits of dataset and QSAR model 
represented by Equation 5 was built up excluding these five compounds.
pMICca= 0.525 J+ 3.015 (5)
n=13, r=0.922, r2=0.851, q2=0.817, s=0.068, F=62.730
The QSAR model represented by Equation 5 has been built up using 13 
compounds and it has got high r, r2, q2, F values, and low S values, which 
supported the fact that model represented by Equation 5 was valid and 
it can be used for prediction of antifungal activity of target compounds 
against C. albicans, and the predicted antimicrobial activity is presented 
in Table 5. Valid QSAR models were not obtained for antibacterial 
activity of test compounds against S. epidermidis.
Docking study
In silico molecular docking studies were executed to investigate the 
possible potential binding modes for these sulfonamide derivatives 
against microbial targets. In the present study, H-bonding, hydrophobic 
interactions, and free binding energy say, and dock score were 
considered for the analysis (Table 6).
In the case of antibacterial activity, all the docked compounds 
showed binding energy from -6.8 kcal/mol to -8.6 kcal/mol. In the 
binding mode of topmost active, compound 13 potently bound to 
1aj0 through four hydrogen bonding and hydrophobic interactions 
(Fig. 1). Hydrogen bonding interactions are as: The oxygen atom of 
SO2NH formed one hydrogen bond with Ser:222 (2.56Å), hydrogen 
atom of COOH created hydrogen bond with Thr:177 (2.50 Å) whereas 
oxygen atom of carbonyl of COOH engaged with Gly:191 (2.57 Å) 
amino acid residue and oxygen atom of NO2 interacted with Arg:220 
amino acid residue with 3.20 Å bond length. In case of hydrophobic 
interactions, Cl of 2,4-dichlorobenzoic acid was involved in alkyl 
interactions with Ala:151, Pro:152 whereas Cl of 2-Cl,4-NO2 
substituted phenyl ring interacted with Lys:221 amino acid residues. 
Pi-alkyl interactions were formed by 2,4-dichloro substituted phenyl 
ring and 2-Cl, 4-NO2 substituted ring with Ala:151 and Pro:64, 
Lys:221 amino acid residues, respectively. Ser:222 amino acid was 
also found to engage with 2-Cl, 4-NO2 substituted phenyl ring through 
pi-sigma interaction.
Second most active compound 18 showed six hydrogen bonding and 
hydrophobic interactions. Compound 18 maintained four hydrogen 
bonding interactions same as compound 13 but two additional bonds 
formed by hydrogen atom of COOH with Asn:144 with a bond length of 
1.84 Å and protonated oxygen of NO2 with Arg:220 with a bond length of 
2.29 Å. In a comparison of compounds 8 (o-F) and 12 (p-F), halogen bond 
was established by ortho substituted fluorine may be contributing to the 
better activity of compound 8. Comparison of 2 (p-Cl) and 12 (p-F), 2 
formed five hydrogen bond interactions whereas, in compound 12, three 
hydrogen bonds were observed. Compound 2 also formed two additional 
hydrophobic interactions such as alkyl interaction with Lys:221 (4.80 Å) 
and pi-alkyl interaction with Phe:190 (4.28 Å) by chlorine which resulted 
in increased in the activity of compound 2. In a comparison of compounds 
5 (p-OCH3), 7 (o-OCH3), and 9 (m-OCH3), pi-pi T-shaped interaction was 
only observed in compound 7 with Phe:190 amino acid residue (4.87 Å).
In the case of antifungal activity, all the compounds displayed binding 
energy from −6.6 kcal/mol to −8.4 kcal/mol. The foremost active 
compound 1 formed two hydrogen bonding, hydrophobic and Van 
der Wall interactions with active binding site (Fig. 2). The protonated 
nitrogen of NO2 created hydrogen bond with His:468 (2.12 Å) amino 
acid residue while NH of SO2NH engaged with Pro:462 (2.24 Å) 
amino acid residue. NO2 substituted phenyl ring established amide-
pi-stacked interaction with Phe:463, pi-alkyl interaction with Ile:379 
and pi-sulfur interaction with Cys:470 amino acid residues. The Cl of 
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Table 3: Correlation matrix for pMICsa with molecular descriptors of 2,4-dichloro benzoic acid derivatives
logP MR 0χ 1χ 2χ κα3 R J W LUMO HOMO pMICsa
logP 1.000
MR 0.718 1.000
0χ 0.565 0.948 1.000
1χ 0.587 0.959 0.989 1.000
2χ 0.634 0.942 0.985 0.977 1.000
κα3 0.180 0.587 0.623 0.589 0.552 1.000
R 0.587 0.959 0.989 1.000 0.977 0.589 1.000
J −0.722 −0.877 −0.831 −0.888 −0.877 −0.344 −0.888 1.000
W 0.529 0.936 0.995 0.985 0.976 0.667 0.985 −0.828 1.000
LUMO −0.422 −0.748 −0.881 −0.829 −0.876 −0.682 −0.829 0.629 −0.897 1.000
HOMO 0.435 0.493 0.329 0.440 0.367 −0.063 0.440 −0.702 0.325 0.050 1.000
pMICsa 0.728 0.970 0.961 0.959 0.965 0.583 0.959 −0.863 0.948 −0.838 0.382 1.000
LUMO: Lowest unoccupied molecular orbital, HOMO: Highest occupied molecular orbital
Table 4: Correlation of molecular descriptors with antimicrobial activity of 2,4−dichloro benzoic acid derivatives
pMICsa pMICbs pMICse pMICec pMICpa pMICca pMICan
logP 0.728 0.728 0.298 0.728 0.728 0.261 0.728
MR 0.970 0.970 0.098 0.970 0.970 0.534 0.970
0χ 0.961 0.961 −0.031 0.961 0.961 0.492 0.961
0χv 0.952 0.952 0.157 0.952 0.952 0.459 0.952
1χ 0.959 0.959 −0.001 0.959 0.959 0.561 0.959
1χv 0.951 0.951 0.166 0.951 0.951 0.464 0.951
2χ 0.965 0.965 0.015 0.965 0.965 0.505 0.965
2χv 0.899 0.899 0.241 0.899 0.899 0.339 0.899
3χ 0.823 0.823 0.021 0.823 0.823 0.269 0.823
3χv 0.561 0.561 0.262 0.561 0.561 0.075 0.561
κ1 0.934 0.934 −0.073 0.934 0.934 0.452 0.934
κ2 0.861 0.861 −0.085 0.861 0.861 0.504 0.861
κ3 0.757 0.757 −0.023 0.757 0.757 0.427 0.757
κα1 0.938 0.938 −0.026 0.938 0.938 0.386 0.938
κα2 0.816 0.816 −0.006 0.816 0.816 0.404 0.816
κα3 0.583 0.583 0.122 0.583 0.583 0.201 0.583
R 0.959 0.959 −0.001 0.959 0.959 0.561 0.959
J −0.863 −0.863 −0.211 −0.863 −0.863 −0.671 −0.863
W 0.948 0.948 0.007 0.948 0.948 0.515 0.948
Te −0.948 −0.948 0.036 −0.948 −0.948 −0.417 −0.948
ElE −0.953 −0.953 0.097 −0.953 −0.953 −0.438 −0.953
NuE 0.951 0.951 −0.106 0.951 0.951 0.440 0.951
LUMO −0.838 −0.838 −0.024 −0.838 −0.838 −0.314 −0.838
HOMO 0.382 0.382 0.316 0.382 0.382 0.596 0.382
μ 0.381 0.381 -0.148 0.381 0.381 0.231 0.381
Table 5: Comparison of observed, predicted, and residual 
activity of 2,4-dichloro benzoic acid derivatives
Comp pMICsaMLR (Eq. 3) pMICca (Eq. 5)
obs pre res obs pre res
1 1.496 1.495 0.001 2.102 2.077 0.025
2 1.484 1.478 0.006 2.086 2.069 0.017
3 1.496 1.495 0.001 - - -
4 1.484 1.479 0.005 2.086 2.045 0.041
5 1.479 1.485 −0.006 2.081 2.077 0.004
6 - - - 2.066 2.069 −0.003
7 1.479 1.486 −0.007 2.081 2.034 0.047
8 1.465 1.454 0.011 2.071 2.045 0.026
9 1.479 1.486 −0.007 2.081 2.068 0.013
10 1.484 1.479 0.005 - - -
11 1.500 1.506 −0.006 - - -
12 1.465 1.454 0.011 - - -
13 1.533 1.522 0.011 1.836 2.046 −0.210
14 1.496 1.495 0.001 2.102 2.065 0.037
15 1.417 1.425 −0.008 1.719 1.726 −0.007
16 1.398 1.401 −0.003 1.699 1.708 −0.009
17 1.398 1.400 −0.002 1.699 1.680 0.019
18 1.511 1.522 −0.011 - - -
Table 6: The Docking score of reported compounds with 
PDB (1aj0, 5fsa)
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Ala:476, Cys:470 while 2,4-dichloro substituted phenyl ring engaged 
with Cys:470, Thr:311 amino acid residues by forming pi-alkyl and pi-
sigma interactions, respectively. Gly:464 amino acid residue formed Van 
der wall interaction with this compound.
In a comparison of a compound containing NO2 substitution, compounds 
1, 3, and 14, amide-pi-stacked interaction was only found in compound 
1, substituted with p-NO2 group. Compound 2 (p-Cl) formed a similar 
type of interactions as compared to compound 12 (p-F) with two more 
Fig. 1: Binding interactions of compound 13 with the active site of 1aj0
Fig. 2: Binding interactions of compound 1 with active site of 5fsa
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interactions such as alkyl and pi-alkyl interaction with Ile:379 and 
Phe:105 amino acid residues, respectively, that resulted in an increase 
in antifungal potential. Compounds with aliphatic substitutions such 
as 15, 16, and 17, amide-pi-stacked, and pi-pi stacked interactions 
were not observed which might have contributed for the decrease in 
antifungal potential.
CONCLUSION
The set of 18 test compounds was subjected to antimicrobial evaluation 
and results depicted that compounds with NO2 substitution were 
most active and para-substituted nitro group effectively increase the 
antimicrobial potential as compared to substitution at ortho and meta 
positions. The compounds with chloro substitution were found to be 
better in activity in comparison to other halogen substituents. The 
QSAR studies depicted the involvement of lipophilic parameter MR 
and Balaban index (J) as governors of antimicrobial potential in case 
of antibacterial and antifungal activity, respectively. Docking studies 
correlated the activity with structural features by depicting various 
interaction modes through which the test compounds were interacting 
with microbial targets such as hydrophobic, hydrogen bonding, and Van 
der Wall interactions.
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